EGFR and neoplasm: EGFR amplification was observed in 6 of 66 OED cases (9.1%), including 2 patients with mild dysplasia and 3 patients with moderate dysplasia; the remaining patient later developed metachronous squamous cell carcinoma and died of tumor progression.